Merck, Emergent, Affinivax and Ocugen Level Up in Vaccine Development

The week began with positive updates in the vaccine development space against various infectious diseases, including pneumococcal disease, SARS-CoV-2 and a chikungunya virus-like illness. BioSpace highlights four of these below.